Common use of Compass Array Library Clause in Contracts

Compass Array Library. Within ten (10) business days of the Effective Date, ArQule will supply SB with one (1) copy of the Compass Array Library in accordance with the specifications set forth in Schedule A attached hereto. During the Screening Phase, SB will screen the ArQule Compounds within the Compass Array Library against Anti-Infective Targets using efforts consistent with its normal scientific and business practices. In addition, SB may also screen the Compass Array Library against Anti-Fungal Targets and other Targets as set forth in Subsection 4.1.6 below. SB shall periodically submit to ArQule a list containing the array plate number and well number of all Active Compounds by facsimile transmission followed by a confirmatory letter. ArQule will promptly determine whether the listed Active Compounds are Available Compounds and notify SB of such determination. If any Active Compound is not an Available Compound, ArQule shall not disclose the structure and SB shall have no rights under this Agreement with respect to that Active Compound; provided however, that ArQule shall promptly notify SB if such Active Compound later becomes an Available Compound. If an Active Compound is an Available Compound, ArQule shall reserve such Active Compound as an Available Compound to SB under this Agreement and, promptly thereafter, ArQule shall disclose to SB the structure of such Available Compound correlated to its well location. Upon request of SB, ArQule shall disclose which Mapping Array Library corresponds to any Active Compound whether or not such ArQule Compound is an Available Compound, including the Markush structure of the Mapping Array Library, as described in Schedule A.

Compass Array Library. Within ten (10) business days of the Effective Date, ArQule will supply SB with one (1) copy of the Compass Array Library in accordance with the specifications set forth in Schedule A attached hereto. During the Screening Phase, SB will screen the ArQule Compounds within the Compass Array Library against Anti-Infective ***** Targets using efforts consistent with its normal scientific and business practices. In addition, SB may also screen the Compass Array Library against Anti-Fungal ***** Targets and other Targets as set forth in Subsection 4.1.6 below. SB shall periodically submit to ArQule a list containing the array plate number and well number of all Active Compounds by facsimile transmission followed by a confirmatory letter. ArQule will promptly determine whether the listed Active Compounds are Available Compounds and notify SB of such determination. If any Active Compound is not an Available Compound, ArQule shall not disclose the structure and SB shall have no rights under this Agreement with respect to that Active Compound; provided however, that ArQule shall promptly notify SB if such Active Compound later becomes an Available Compound. If an Active Compound is an Available Compound, ArQule shall reserve such Active Compound as an Available Compound to SB under this Agreement and, promptly thereafter, ArQule shall disclose to SB the structure of such Available Compound correlated to its well location. Upon request of SB, ArQule shall disclose which Mapping Array Library corresponds to any Active Compound whether or not such ArQule Compound is an Available Compound, including the Markush structure of the Mapping Array Library, as described in Schedule A.